RTX carries a strong balance sheet with a BBB+ credit rating from S&P. This is supported by $5.2 billion in cash on hand, and ...

North Chicago, Illinois-based AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. With ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

Toon Van Gorp, MD, PhD, discusses the rationale behind and the findings from the phase 3 MIRASOL trial of mirvetuximab ...

AbbVie is sprinting beyond its Humira dependency by banking on rising stars Skyrizi and Rinvoq, which are smashing sales ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

Patients received Dato-DXd 6 mg/kg once every 3 weeks. The primary end point was objective response rate (ORR) by blinded independent central review. Secondary end points included duration of response ...

Select FDA Patent Term Extension Application for Elahere (mirvetuximab soravtansine-gynx), Patent No. 8,557,966 FDA-2023-E-3231 Select FDA Patent Term Extension Application for Elahere (mirvetuximab ...

Future Oncol. 2012;8(2):151-164. DNA methylation is arguably the most intensively studied aspect of epigenetics with regard to carcinogenesis, and has also been the major focus of pharmacological ...